{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:15:24Z","timestamp":1760267724259},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:00:00Z","timestamp":1586476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:00:00Z","timestamp":1586476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Comparative Medicine Institute, NC State University"},{"name":"AAUW International Fellowship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We report on a new cheminformatics enumeration technology\u2014SIME, synthetic insight-based macrolide enumerator\u2014a new and improved software technology. SIME can enumerate fully assembled macrolides with synthetic feasibility by utilizing the constitutional and structural knowledge extracted from biosynthetic aspects of macrolides. Taken into account by the software are key information such as positions in macrolide structures at which chemical components can be inserted, and the types of structural motifs and sugars of interest that can be synthesized and incorporated at those positions. Additionally, we report on the chemical distribution analysis of the newly SIME-generated V1B (virtual 1 billion) library of macrolides. Those compounds were built based on the core of the Erythromycin structure, 13 structural motifs and a library of sugars derived from eighteen bioactive macrolides. This new enumeration technology can be coupled with cheminformatics approaches such as QSAR modeling and molecular docking to aid in drug discovery for rational designing of next generation macrolide therapeutics with desirable pharmacokinetic properties.<\/jats:p>","DOI":"10.1186\/s13321-020-00427-6","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T11:02:18Z","timestamp":1586516538000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["SIME: synthetic insight-based macrolide enumerator to generate the V1B library of 1 billion macrolides"],"prefix":"10.1186","volume":"12","author":[{"given":"Phyo Phyo Kyaw","family":"Zin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Fourches","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,10]]},"reference":[{"key":"427_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/31.suppl_C.1","volume":"31","author":"T Mazzei","year":"1993","unstructured":"Mazzei T, Mini E, Novelli A, Periti P (1993) Chemistry and mode of action of macrolides. J Antimicrob Chemother 31:1\u20139. https:\/\/doi.org\/10.1093\/jac\/31.suppl_C.1","journal-title":"J Antimicrob Chemother"},{"key":"427_CR2","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1128\/CMR.00078-09","volume":"23","author":"S Kanoh","year":"2010","unstructured":"Kanoh S, Rubin BK (2010) Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev 23:590\u2013615. https:\/\/doi.org\/10.1128\/CMR.00078-09","journal-title":"Clin Microbiol Rev"},{"key":"427_CR3","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1111\/bph.13936","volume":"174","author":"C Dinos","year":"2017","unstructured":"Dinos C, George P, Dinos GP (2017) The macrolide antibiotic renaissance. Br J Pharmacol 174:2967. https:\/\/doi.org\/10.1111\/bph.13936","journal-title":"Br J Pharmacol"},{"key":"427_CR4","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1517\/13543776.13.6.787","volume":"13","author":"TC Henninger","year":"2003","unstructured":"Henninger TC (2003) Recent progress in the field of macrolide antibiotics. Expert Opin Ther Pat 13:787\u2013805. https:\/\/doi.org\/10.1517\/13543776.13.6.787","journal-title":"Expert Opin Ther Pat"},{"key":"427_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.cbpa.2012.01.018","volume":"16","author":"FT Wong","year":"2012","unstructured":"Wong FT, Khosla C (2012) Combinatorial biosynthesis of polyketides-a perspective. Curr Opin Chem Biol 16:117\u2013123. https:\/\/doi.org\/10.1016\/j.cbpa.2012.01.018","journal-title":"Curr Opin Chem Biol"},{"key":"427_CR6","volume-title":"Macrocycles: under-explored and poorly exploited drug class despite the proven therapeutic potential","author":"P Raboisson","year":"2015","unstructured":"Raboisson P (2015) Macrocycles: under-explored and poorly exploited drug class despite the proven therapeutic potential. Elsevier Ltd, Amsterdam"},{"key":"427_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development Settings. Adv Drug Deliv Rev 23:3\u201325. https:\/\/doi.org\/10.1016\/S0169-409X(00)00129-0","journal-title":"Adv Drug Deliv Rev"},{"key":"427_CR8","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"D Kk","year":"2002","unstructured":"Kk D, Veber DF, Johnson SR et al (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45:2615\u20132623. https:\/\/doi.org\/10.1021\/jm020017n","journal-title":"J Med Chem"},{"key":"427_CR9","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/nrd2590","volume":"7","author":"EM Driggers","year":"2008","unstructured":"Driggers EM, Hale SP, Lee J, Terrett NK (2008) The exploration of macrocycles for drug discovery\u2014an underexploited structural class. Nat Rev Drug Discov 7:608\u2013624. https:\/\/doi.org\/10.1038\/nrd2590","journal-title":"Nat Rev Drug Discov"},{"key":"427_CR10","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nchembio.1584","volume":"10","author":"EA Villar","year":"2014","unstructured":"Villar EA, Beglov D, Chennamadhavuni S et al (2014) How proteins bind macrocycles. Nat Chem Biol 10:723\u2013731. https:\/\/doi.org\/10.1038\/nchembio.1584","journal-title":"Nat Chem Biol"},{"key":"427_CR11","doi-asserted-by":"publisher","DOI":"10.1021\/ja063076p","author":"T Rezai","year":"2006","unstructured":"Rezai T, Bock JE, Zhou MV et al (2006) Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic. Peptides. https:\/\/doi.org\/10.1021\/ja063076p","journal-title":"Peptides"},{"key":"427_CR12","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.chembiol.2014.08.013","volume":"21","author":"BC Doak","year":"2014","unstructured":"Doak BC, Over B, Giordanetto F, Kihlberg J (2014) Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates. Chem Biol 21:1115\u20131142","journal-title":"Chem Biol"},{"key":"427_CR13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1021\/ci3001056","volume":"57","author":"F Giordanetto","year":"2012","unstructured":"Giordanetto F, Kihlberg J, Peragovics \u00c1 et al (2012) Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties? J Med Chem 57:278\u2013295. https:\/\/doi.org\/10.1021\/ci3001056","journal-title":"J Med Chem"},{"key":"427_CR14","doi-asserted-by":"publisher","first-page":"6420","DOI":"10.1016\/j.bmc.2016.08.035","volume":"24","author":"P Fernandes","year":"2016","unstructured":"Fernandes P, Martens E, Bertrand D, Pereira D (2016) The solithromycin journey\u2014it is all in the chemistry. Bioorganic Med Chem 24:6420\u20136428. https:\/\/doi.org\/10.1016\/j.bmc.2016.08.035","journal-title":"Bioorganic Med Chem"},{"key":"427_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1345\/aph.19138","volume":"34","author":"MP Pai","year":"2000","unstructured":"Pai MP, Graci DM, Amsden GW (2000) Macrolide drug interactions: an update. Ann Pharmacother 34:495\u2013513","journal-title":"Ann Pharmacother"},{"key":"427_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-018-0307-6","author":"PPK Zin","year":"2018","unstructured":"Zin PPK, Williams G, Fourches D (2018) Cheminformatics-based enumeration and analysis of large libraries of macrolide scaffolds. J Cheminform. https:\/\/doi.org\/10.1186\/s13321-018-0307-6","journal-title":"J Cheminform"},{"key":"427_CR17","doi-asserted-by":"publisher","first-page":"11713","DOI":"10.1074\/jbc.275.16.11713","volume":"275","author":"LM Quir\u00f3s","year":"2000","unstructured":"Quir\u00f3s LM, Carbajo RJ, Bra\u00f1a AF, Salas JA (2000) Glycosylation of macrolide antibiotics. Purification and kinetic studies of a macrolide glycosyltransferase from Streptomyces antibioticus. J Biol Chem 275:11713\u201311720. https:\/\/doi.org\/10.1074\/jbc.275.16.11713","journal-title":"J Biol Chem"},{"key":"427_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1097-2765(02)00570-1","volume":"10","author":"JL Hansen","year":"2002","unstructured":"Hansen JL, Ippolito JA, Ban N et al (2002) The structures of four macrolide antibiotics bound to the large ribosomal subunit. Mol Cell 10:117\u2013128. https:\/\/doi.org\/10.1016\/S1097-2765(02)00570-1","journal-title":"Mol Cell"},{"key":"427_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/antibiotics5030029","volume":"5","author":"D Jeli\u0107","year":"2016","unstructured":"Jeli\u0107 D, Antolovi\u0107 R (2016) From erythromycin to azithromycin and new potential ribosome-binding antimicrobials. Antibiotics 5:29. https:\/\/doi.org\/10.3390\/antibiotics5030029","journal-title":"Antibiotics"},{"key":"427_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11882-005-0046-4","volume":"5","author":"AA White","year":"2005","unstructured":"White AA, Simon RA (2005) Macrolide antibiotics as anti-inflammatory agents. Curr Allergy Asthma Rep 5:1\u20133. https:\/\/doi.org\/10.1007\/s11882-005-0046-4","journal-title":"Curr Allergy Asthma Rep"},{"key":"427_CR21","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.pupt.2009.08.004","volume":"22","author":"Y Morinaga","year":"2009","unstructured":"Morinaga Y, Yanagihara K, Miyashita N et al (2009) Azithromycin, clarithromycin and telithromycin inhibit MUC5AC induction by Chlamydophila pneumoniae in airway epithelial cells. Pulm Pharmacol Ther 22:580\u2013586. https:\/\/doi.org\/10.1016\/j.pupt.2009.08.004","journal-title":"Pulm Pharmacol Ther"},{"key":"427_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1365-2125.1982.tb02018.x","volume":"14","author":"A Iliopoulou","year":"1982","unstructured":"Iliopoulou A, Aldhous M, Johnston A, Turner P (1982) Pharmacokinetic interaction between theophylline and erythromycin. Br J Clin Pharmacol 14:495\u2013499. https:\/\/doi.org\/10.1111\/j.1365-2125.1982.tb02018.x","journal-title":"Br J Clin Pharmacol"},{"key":"427_CR23","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1128\/AAC.05596-11","volume":"56","author":"ML English","year":"2012","unstructured":"English ML, Fredericks CE, Milanesio NA et al (2012) Cethromycin versus clarithromycin for community-acquired pneumonia: comparative efficacy and safety outcomes from two double-blinded, randomized, parallel-group, multicenter, multinational noninferiority studies. Antimicrob Agents Chemother 56:2037\u20132047. https:\/\/doi.org\/10.1128\/AAC.05596-11","journal-title":"Antimicrob Agents Chemother"},{"key":"427_CR24","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1128\/AAC.46.9.2727-2734.2002","volume":"46","author":"R Leclercq","year":"2002","unstructured":"Leclercq R, Courvalin P (2002) Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Antimicrob Agents Chemother 46:2727\u20132734. https:\/\/doi.org\/10.1128\/AAC.46.9.2727-2734.2002","journal-title":"Antimicrob Agents Chemother"},{"key":"427_CR25","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.idc.2009.06.013","volume":"23","author":"JM Zuckerman","year":"2009","unstructured":"Zuckerman JM, Qamar F, Bono BR (2009) Macrolides, ketolides, and glycylcyclines: azithromycin, clarithromycin, telithromycin, tigecycline. Infect Dis Clin North Am 23:997\u20131026. https:\/\/doi.org\/10.1016\/j.idc.2009.06.013","journal-title":"Infect Dis Clin North Am"},{"key":"427_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63192-4","author":"PP Zin","year":"2020","unstructured":"Zin PP, Williams G, Ekins S (2020) Cheminformatics analysis and modeling with MacrolactoneDB. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-020-63192-4","journal-title":"Sci Rep"},{"key":"427_CR27","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1021\/acs.jcim.7b00052","volume":"57","author":"D Sindhikara","year":"2017","unstructured":"Sindhikara D, Spronk SA, Day T et al (2017) Improving accuracy, diversity, and speed with prime macrocycle conformational sampling. J Chem Inf Model 57:1881\u20131894. https:\/\/doi.org\/10.1021\/acs.jcim.7b00052","journal-title":"J Chem Inf Model"},{"key":"427_CR28","doi-asserted-by":"publisher","DOI":"10.5334\/jors.189","author":"X Barbeau","year":"2018","unstructured":"Barbeau X, Vincent AT, Lag\u00fce P (2018) ConfBuster: open-source tools for macrocycle conformational search and analysis. J Open Res Softw. https:\/\/doi.org\/10.5334\/jors.189","journal-title":"J Open Res Softw"},{"key":"427_CR29","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nchembio.1580","volume":"10","author":"J Gavenonis","year":"2014","unstructured":"Gavenonis J, Sheneman BA, Siegert TR et al (2014) Comprehensive analysis of loops at protein-protein interfaces for macrocycle design. Nat Chem Biol 10:716\u2013722. https:\/\/doi.org\/10.1038\/nchembio.1580","journal-title":"Nat Chem Biol"},{"key":"427_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/636157","author":"B Kwiatkowska","year":"2012","unstructured":"Kwiatkowska B, Ma\u00b4sl\u00ed MM (2012) Macrolide therapy in chronic inflammatory diseases. Mediators Inflamm. https:\/\/doi.org\/10.1155\/2012\/636157","journal-title":"Mediators Inflamm"},{"key":"427_CR31","doi-asserted-by":"publisher","unstructured":"Greg Landrum, Landrum G, Greg Landrum, Landrum G (2019) RDKit Documentation. Release 2017091. https:\/\/doi.org\/10.5281\/zenodo.60510","DOI":"10.5281\/zenodo.60510"},{"key":"427_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.addr.2016.04.029","volume":"101","author":"CA Lipinski","year":"2016","unstructured":"Lipinski CA (2016) Rule of five in 2015 and beyond: target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions. Adv Drug Deliv Rev 101:34\u201341","journal-title":"Adv Drug Deliv Rev"},{"key":"427_CR33","first-page":"159","volume":"63","author":"A Pyka","year":"2006","unstructured":"Pyka A, Babuska M, Magdalena Z (2006) (PDF) A comparison of theoretical methods of calculation of partition coefficients for selected drugs. Acta Pol Pharm Drug Res 63:159\u2013167","journal-title":"Acta Pol Pharm Drug Res"},{"key":"427_CR34","doi-asserted-by":"publisher","first-page":"9724","DOI":"10.1021\/acs.chemrev.8b00742","volume":"119","author":"SD Appavoo","year":"2019","unstructured":"Appavoo SD, Huh S, Diaz DB, Yudin AK (2019) Conformational control of macrocycles by remote structural modification. Chem Rev 119:9724\u20139752. https:\/\/doi.org\/10.1021\/acs.chemrev.8b00742","journal-title":"Chem Rev"},{"key":"427_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00894-019-4077-5","author":"I Ugur","year":"2019","unstructured":"Ugur I, Schroft M, Marion A et al (2019) Predicting the bioactive conformations of macrocycles: a molecular dynamics-based docking procedure with DynaDock. J Mol Model. https:\/\/doi.org\/10.1007\/s00894-019-4077-5","journal-title":"J Mol Model"},{"issue":"4","key":"427_CR36","first-page":"491","volume":"26","author":"S Belaidi","year":"2002","unstructured":"Belaidi S, Dibi A, Omari M (2002) A conformational exploration of dissymmetric macrolides antibiotics. Turk J Chem 26(4):491\u2013500","journal-title":"Turk J Chem"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-020-00427-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13321-020-00427-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-020-00427-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T23:33:32Z","timestamp":1618011212000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/s13321-020-00427-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,10]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["427"],"URL":"https:\/\/doi.org\/10.1186\/s13321-020-00427-6","relation":{},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,10]]},"assertion":[{"value":"30 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}